Use of intravitreal triamcinolone in the management of birdshot retinochoroidopathy associated with cystoid macular oedema: a case study over a three-year period.
Birdshot retinochoroidopathy is a bilateral, chronic posterior uveitis of likely autoimmune aetiology characterized by multiple depigmented choroidal lesions scattered throughout the post-equatorial retina. It has been managed with variable results using systemic immunosuppression. Herein, a case is described in which the patient, aware of the side-effects of systemic immunosuppression, refused this form of treatment and was successfully managed over a 3-year period with intravitreal triamcinolone. She developed the ocular complications of cataract and increased intraocular pressures, but maintained good vision while avoiding any systemic side-effects.
Shah
Anup
A
North Shore Eye Centre, North Shore Private Hospital, Sydney, New South Wales, Australia.
Branley
Michael
M
D000328:Adult; D015862:Choroid Diseases / Q000150:complications / Q000188:drug therapy*; D002908:Chronic Disease; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology; D012164:Retinal Diseases / Q000150:complications / Q000188:drug therapy*; D019233:Retreatment; D016896:Treatment Outcome; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*; D015866:Uveitis, Posterior / Q000150:complications / Q000188:drug therapy*; D014792:Visual Acuity; D014822:Vitreous Body
D005938:Glucocorticoids; D014222:Triamcinolone Acetonide